Enhanced Liver Fibrosis Score Stratifies Hepatocellular Carcinoma Risk in Patients With Hepatitis B Surface Antigen Seroclearance

被引：3
|
作者：
Mak, Lung-Yi [1 ,2 ]
Cheung, Ka-Shing [1 ,3 ]
Hui, Rex Wan-Hin [1 ]
Wong, Danny Ka-Ho [1 ,2 ]
Fung, James [1 ,2 ]
Yuen, Man-Fung [1 ,2 ]
Seto, Wai-Kay [1 ,2 ,3 ]
机构：
[1] Univ Hong Kong, Queen Mary Hosp, Dept Med, Pokfulam Rd 102, Hong Kong, Peoples R China
[2] Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Peoples R China
[3] Univ Hong Kong, Dept Med, Shenzhen Hosp, Shenzhen, Peoples R China
来源：
CLINICAL INFECTIOUS DISEASES | 2022年 / 75卷 / 12期
关键词：
hepatitis B virus (HBV); enhanced liver fibrosis (ELF); functional cure; hepatocellular carcinoma ( HCC); HBSAG SEROCLEARANCE;
D O I：
10.1093/cid/ciac387
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
In this prospective study involving 337 chronic hepatitis B patients who achieved spontaneous hepatitis B surface antigen (HBsAg) seroclearance (SC), serum enhanced liver fibrosis (ELF) before SC was associated with hepatocellular carcinoma (HCC) (hazard ratio 2.588), and ELF 97% reduction in risk of HCC development in patients with age SC >= 50 (n = 190).
引用
收藏
页码：2257 / 2259
页数：3
相关论文
共 50 条
  • [31] Predictive Factors Associated with Hepatocellular Carcinoma Incidence and Mortality after Hepatitis B Surface Antigen Seroclearance in Patients with Chronic Hepatitis B
    Hosaka, Tetsuya
    Suzuki, Fumitaka
    Kobayashi, Masahiro
    Fujiyama, Shunichiro
    Kawamura, Yusuke
    Sezaki, Hitomi
    Akuta, Norio
    Suzuki, Yoshiyuki
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kobayashi, Mariko
    Kumada, Hiromitsu
    HEPATOLOGY, 2018, 68 : 133A - 134A
  • [32] Systematic review with meta-analysis: development of hepatocellular carcinoma in chronic hepatitis B patients with hepatitis B surface antigen seroclearance
    Liu, F.
    Wang, X. -W.
    Chen, L.
    Hu, P.
    Ren, H.
    Hu, H. -D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (12) : 1253 - 1261
  • [33] Persistence of intrahepatic hepatitis B virus DNA integration in patients developing hepatocellular carcinoma after hepatitis B surface antigen seroclearance
    Jang, Jeong Won
    Kim, Jin Seoub
    Kim, Hye Seon
    Tak, Kwon Yong
    Nam, Heechul
    Sung, Pil Soo
    Bae, Si Hyun
    Choi, Jong Young
    Yoon, Seung Kew
    Roberts, Lewis R.
    CLINICAL AND MOLECULAR HEPATOLOGY, 2021, 27 (01) : 207 - 218
  • [34] Changes of enhanced liver fibrosis score predict hepatocellular carcinoma in chronic hepatitis B patients receiving antiviral treatment
    Liang, Yan
    Yip, Terry Cheuk-Fung
    Lai, Che To
    Lam, Shuk Man
    Tse, Yee-Kit
    Hui, Vicki Wing-Ki
    Chan, Henry L. Y.
    Wong, Vincent Wai-Sun
    Wong, Grace
    JOURNAL OF HEPATOLOGY, 2022, 77 : S302 - S302
  • [35] Cumulative incidence of hepatocellular carcinoma and hepatitis B surface antigen Seroclearance after Nucleos(t) ide analogue-induced hepatitis B e antigen Seroclearance
    Lee, Hyun Woong
    Lee, Jung Il
    Kim, Saein
    Kim, Sora
    Chang, Hye Young
    Lee, Kwan Sik
    BMC GASTROENTEROLOGY, 2020, 20 (01)
  • [36] Cumulative incidence of hepatocellular carcinoma and hepatitis B surface antigen Seroclearance after Nucleos(t) ide analogue-induced hepatitis B e antigen Seroclearance
    Hyun Woong Lee
    Jung Il Lee
    Saein Kim
    Sora Kim
    Hye Young Chang
    Kwan Sik Lee
    BMC Gastroenterology, 20
  • [37] Prediction of hepatocellular carcinoma in chronic hepatitis B patients following HBsAg seroclearance: Lage score
    Choi, Jonggi
    Kim, Eunju
    Choi, Won-Mook
    Lee, Danbi
    Kim, Kang Mo
    Shim, Ju Hyun
    Lim, Young-Suk
    Lee, Han Chu
    JOURNAL OF HEPATOLOGY, 2023, 78 : S1062 - S1063
  • [38] Risk prediction model for hepatocellular carcinoma after hepatitis b e antigen seroclearance in patients treated with entecavir or tenofovir
    Lim, Tae Seop
    Jeon, Mi Young
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Han, Kwang-Hyub
    Kim, Seung Up
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E264 - E264
  • [39] Hepatitis B: Liver fibrosis and hepatocellular carcinoma
    Lok, A. S. F.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2009, 33 (10-11): : 911 - 915
  • [40] Enhanced Liver Fibrosis Score as a Predictor of Hepatocellular Carcinoma
    Loo, Wai Mun
    Goh, George Boon-Bee
    Wang, Yeli
    Yuan, Jian-Min
    Ong, Lizhen
    Dan, Yock Young
    Koh, Woon-Puay
    CLINICAL CHEMISTRY, 2018, 64 (09) : 1404 - 1405
12345